[Molecular targeting therapy for chronic myeloid leukemia]. [electronic resource]
Producer: 20070406Description: 46-55 p. digitalISSN:- 0485-1439
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Clinical Trials, Phase II as Topic
- Dasatinib
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Middle Aged
- Philadelphia Chromosome
- Piperazines -- chemistry
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- chemistry
- Thiazoles -- chemistry
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.